ADMA Group is a diversified group of companies involved in various aspects in the field of metallurgy including manufacturing, processing, Research & Development, Consulting, Government Contracts, trade and others. The companies employ well-known metallurgists and scientists and possess modern equipment supporting these diversified activities.

Asymmetric dimethylarginine (ADMA) is a naturally occurring component of human blood plasma. It is formed as a metabolic byproduct of continuous protein turnover in all cells of the body. More than one decade ago ADMA was first reported to exert biological effects by inhibiting NO synthesis. Starting with this initial finding, the pathophysiological role of ADMA has subsequently been elucidated in more detail by the collaborative efforts of many groups of researchers throughout the world. Many researchers today agree that ADMA may play a prominent role in the pathogenesis and in the progression of cardiovascular diseases - specifically atherosclerosis. The clinical role of ADMA as a marker of cardiovascular risk can be deduced from an increasing number of clinical studies that have demonstrated the presence of a statistically significant and independent relationship between ADMA and the incidence of major adverse cardiovascular events or death [89]. In Figure 25 diseases have been highlighted in which elevation of ADMA may play an important pathophysiological role.

ADMA is an association for distributors and manufacturers of aviation parts, supplies and components, increasing productivity and profitablity in the aviation community.